Interscope Med Ltd

Interscope Med Ltd is a small, active company based in London, UK, founded eight years ago. With a single employee and £36,656 in assets, it operates from a virtual address shared by 169 other companies, raising some questions. The company has two directors but no officially listed owners, a common situation for smaller firms. It’s an irregular importer, primarily dealing with optical and medical tools and devices, with its last import activity occurring two months ago in July 2023.

The company’s website paints a picture of a specialized medical device provider. Interscope Med focuses on endoscopic procedures, offering a next-generation interventional device called the EndoRotor, designed to address challenges in tissue resection and debridement. The website details the device's use in various procedures, including pancreatic necrosis treatment and lesion removal, showcasing testimonials from physicians highlighting its effectiveness and safety. The site also includes information for patients and details ongoing clinical studies, demonstrating a commitment to innovation and research.

Financially, Interscope Med Ltd shows a mixed bag. While cash bank on hand increased significantly by 2700% to £13,000, comprehensive income expenses plummeted by 700% to -£78,000. Net assets decreased by 31% to -£570,000, and trade debtors remained steady. The company’s small size—meeting two of three criteria for a small company—helps with agility, but the substantial losses and negative equity suggest it’s burning through cash. The lack of an auditor (likely exempt due to its small size) means the figures are unaudited. It’s likely that the company is facing challenges in converting sales into profits, or perhaps it’s heavily investing in research and development.

Registered in England/Wales under the registration number 10569695, with a registered address at EC3V 9DU, United Kingdom, London, Birchin Court 5th Floor, 19-25 Birchin Lane.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.